C12Y 204/02
Pentosyltransferases
Official title: Pentosyltransferases (2.4.2)
C12Y204/02 (Pentosyltransferases) appears on 250 US grants and 498 published applications in this corpus.
Search patents in C12Y- Granted patents
- 250
- Published applications
- 498
- Assignees
- 266
- Inventors
- 1,071
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 0 |
| 2002 | 5 | 3 |
| 2003 | 5 | 7 |
| 2004 | 2 | 7 |
| 2005 | 0 | 3 |
| 2006 | 2 | 4 |
| 2007 | 2 | 3 |
| 2008 | 3 | 0 |
| 2009 | 3 | 4 |
| 2010 | 2 | 6 |
| 2011 | 0 | 7 |
| 2012 | 4 | 9 |
| 2013 | 4 | 11 |
| 2014 | 9 | 15 |
| 2015 | 11 | 30 |
| 2016 | 13 | 29 |
| 2017 | 14 | 39 |
| 2018 | 16 | 40 |
| 2019 | 19 | 38 |
| 2020 | 26 | 24 |
| 2021 | 21 | 45 |
| 2022 | 21 | 37 |
| 2023 | 16 | 33 |
| 2024 | 14 | 45 |
| 2025 | 20 | 33 |
| 2026 | 8 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 204/02036Nad--diphthamide adp-ribosyltransferase76
- C12Y 204/0203Nad+ adp-ribosyltransferase , i.e. tankyrase or poly polymerase40
- C12Y 204/02008Hypoxanthine phosphoribosyltransferase26
- C12Y 204/02001Purine-nucleoside phosphorylase22
- C12Y 204/02012Nicotinamide phosphoribosyltransferase , i.e. visfatin15
- C12Y 204/02004Thymidine phosphorylase12
- C12Y 204/02003Uridine phosphorylase6
- C12Y 204/0201Orotate phosphoribosyltransferase6
All 47 subgroupsShow fewer
- C12Y 204/02017Atp phosphoribosyltransferase6
- C12Y 204/02009Uracil phosphoribosyltransferase5
- C12Y 204/02018Anthranilate phosphoribosyltransferase5
- C12Y 204/02028S-methyl-5'-thioadenosine phosphorylase5
- C12Y 204/02031Nad+-protein-arginine adp-ribosyltransferase4
- C12Y 204/02011Nicotinate phosphoribosyltransferase3
- C12Y 204/02019Nicotinate-nucleotide diphosphorylase3
- C12Y 204/02038Glycoprotein 2-beta-d-xylosyltransferase3
- C12Y 204/02029Trna-guanosine34 transglycosylase2
- C12Y 204/02006Nucleoside deoxyribosyltransferase1
- C12Y 204/02014Amidophosphoribosyltransferase1
- C12Y 204/02037Nad--dinitrogen-reductase adp-d-ribosyltransferase1
- C12Y 204/02002Pyrimidine-nucleoside phosphorylase0
- C12Y 204/02005Nucleoside ribosyltransferase0
- C12Y 204/02007Adenine phosphoribosyltransferase0
- C12Y 204/02015Guanosine phosphorylase0
- C12Y 204/02016Urate-ribonucleotide phosphorylase0
- C12Y 204/0202Dioxotetrahydropyrimidine phosphoribosyltransferase0
- C12Y 204/02021Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase0
- C12Y 204/02022Xanthine phosphoribosyltransferase0
- C12Y 204/02023Deoxyuridine phosphorylase0
- C12Y 204/020241,4-beta-d-xylan synthase0
- C12Y 204/02025Flavone apiosyltransferase0
- C12Y 204/02026Protein xylosyltransferase0
- C12Y 204/02027Dtdp-dihydrostreptose--streptidine-6-phosphate dihydrostreptosyltransferase0
- C12Y 204/02032Dolichyl-phosphate d-xylosyltransferase0
- C12Y 204/02033Dolichyl-xylosyl-phosphate--protein xylosyltransferase0
- C12Y 204/02034Indolylacetylinositol arabinosyltransferase0
- C12Y 204/02035Flavonol-3-o-glycoside xylosyltransferase0
- C12Y 204/02039Xyloglucan 6-xylosyltransferase0
- C12Y 204/0204Zeatin o-beta-d-xylosyltransferase0
- C12Y 204/02041Xylogalacturonan beta-1,3-xylosyltransferase0
- C12Y 204/02042Udp-d-xylose:beta-d-glucoside alpha-1,3-d-xylosyltransferase0
- C12Y 204/02043Lipid iva 4-amino-4-deoxy-l-arabinosyltransferase0
- C12Y 204/02044S-methyl-5'-thioinosine phosphorylase0
- C12Y 204/02045Decaprenyl-phosphate phosphoribosyltransferase0
- C12Y 204/02046Galactan 5-o-arabinofuranosyltransferase0
- C12Y 204/02047Arabinofuranan 3-o-arabinosyltransferase0
- C12Y 204/02048Trna-guanine15 transglycosylase0
Recent patents
- Viral vectors for treating Parkinson's disease4 Aug 2026US 12,697,360 B2American Gene Technologies International Inc.
- Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy4 Aug 2026US 12,698,482 B2Entrada Therapeutics, Inc.
- Vaccine21 Jul 2026US 12,685,769 B2Glaxosmithkline Biologicals SA
- De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals26 May 2026US 12,637,495 B2Molecular Templates, Inc.
- Guided microbial remodeling, a platform for the rational improvement of microbial species for agriculture28 Apr 2026US 12,612,639 B2Pivot Bio, Inc.
- Novel biosynthesis system for producing 3'-phosphoadenosine-5'-phosphosulfate and application thereof8 Oct 2026US 2026/0308651 A1Jiangnan University
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Production and use of extracellular vesicle-contained enampt10 Sep 2026US 2026/0263365 A1Washington University
- Nicotinamide adenine dinucleotide devices and compositions and methods for making the same27 Aug 2026US 2026/0250695 A1Bio Capital Holdings, LLC
- Method for Enzymatic Synthesis of Nucleoside Bearing Protecting Group, and Composition27 Aug 2026US 2026/0250734 A1Asymchem Life Science (Tianjin) Co., Ltd
Most cited
By later US patents
- Oligoribonucleotides with enzymatic activity72US 6,617,438 B1Sirna Therapeutics, Inc. · 2003
- Muscle targeting complexes and uses thereof for treating dystrophinopathies62US 11,168,141 B2Dyne Therapeutics, Inc. · 2021
- Muscle targeting complexes and uses thereof for treating dystrophinopathies58US 11,248,056 B1Dyne Therapeutics, Inc. · 2022
- Muscle targeting complexes and uses thereof for treating dystrophinopathies56US 11,369,689 B2Dyne Therapeutics, Inc. · 2022
- Synthetic ribonucleic acids with RNAse activity56US 6,528,640 B1Ribozyme Pharmaceuticals, Inc. · 2003